A case report of granulocyte colony-stimulating factor-producing hepatocellular carcinoma that recurred after long-term complete response.


Journal

Clinical journal of gastroenterology
ISSN: 1865-7265
Titre abrégé: Clin J Gastroenterol
Pays: Japan
ID NLM: 101477246

Informations de publication

Date de publication:
Feb 2021
Historique:
received: 27 05 2020
accepted: 13 09 2020
pubmed: 18 10 2020
medline: 29 6 2021
entrez: 17 10 2020
Statut: ppublish

Résumé

The granulocyte colony-stimulating factor (G-CSF) is a glycoprotein that stimulates cell proliferation and differentiation of precursor cells in the bone marrow. Several cases of G-CSF-producing malignant tumors in various organs have been reported, but there are only nine cases of G-CSF-producing hepatocellular carcinoma (HCC) reported in the English literature. G-CSF-producing tumors grow rapidly and have a high probability of distant metastases; thus, they generally have a poor prognosis. Given that the mechanism of the carcinogenesis of G-CSF-producing HCC remains unclear, an efficient treatment strategy also remains to be elucidated. We report herein a case of G-CSF-producing HCC accompanied by leukocytosis and high serum G-CSF concentrations in the disease progression stage after long-term complete response. We also reviewed previous reports to investigate the clinical behaviors of G-CSF-producing HCC, including our case. Clinicians should consider G-CSF-producing HCC in patients with a hepatic mass and drastic leukocytosis, without any evidence of infection and blood disorders. Early diagnosis and prompt therapy, including radical resection, may provide a more favorable prognosis.

Identifiants

pubmed: 33068269
doi: 10.1007/s12328-020-01239-9
pii: 10.1007/s12328-020-01239-9
doi:

Substances chimiques

Granulocyte Colony-Stimulating Factor 143011-72-7

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

204-211

Références

Robinson WA. Granulocytosis in neoplasia. Ann N Y Acad Sci. 1974;230:212–8.
doi: 10.1111/j.1749-6632.1974.tb14451.x
Lieschke GJ, Burgess AW. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor (1). N Engl J Med. 1992;327:28–35.
doi: 10.1056/NEJM199207023270106
Asano S, Urabe A, Okabe T, et al. Demonstration of granulopoietic factor(s) in the plasma of nude mice transplanted with a human lung cancer and in the tumor tissue. Blood. 1977;49:845–52.
doi: 10.1182/blood.V49.5.845.845
Shijubo N, Inoue Y, Hirasawa M, et al. Granulocyte colony-stimulating factor-producing large cell undifferentiated carcinoma of the lung. Intern Med. 1992;31:277–80.
doi: 10.2169/internalmedicine.31.277
Tachibana M, Miyakawa A, Tazaki H, et al. Autocrine growth of transitional cell carcinoma of the bladder induced by granulocyte-colony stimulating factor. Cancer Res. 1995;55:3438–43.
pubmed: 7542171
Ikeda T, Ohgaki K, Miura M, et al. Granulocyte-colony stimulating factor-producing gallbladder cancer without recurrence more than 2 years after resection: report of a case. Surg Today. 2005;35:590–3.
doi: 10.1007/s00595-004-2981-4
Nakajima A, Takahashi H, Inamori M, et al. Anaplastic carcinoma of the pancreas producing granulocyte-colony stimulating factor: a case report. J Med Case Rep. 2008;2:391.
doi: 10.1186/1752-1947-2-391
Iwasa K, Noguchi M, Mori K, et al. Anaplastic thyroid carcinoma producing the granulocyte colony stimulating factor (G-CSF): report of a case. Surg Today. 1995;25:158–60.
doi: 10.1007/BF00311090
Kyo S, Kanaya T, Takakura M, et al. A case of cervical cancer with aggressive tumor growth: possible autocrine growth stimulation by G-CSF and Il-6. Gynecol Oncol. 2000;78:383–7.
doi: 10.1006/gyno.2000.5904
Nagamatsu H, Hiraki M, Mizukami N, et al. Intra-arterial therapy with cisplatin suspension in lipiodol and 5-fluorouracil for hepatocellular carcinoma with portal vein tumour thrombosis. Aliment Pharmacol Ther. 2010;32:543–50.
doi: 10.1111/j.1365-2036.2010.04379.x
Yamamoto S, Takashima S, Ogawa H, et al. Granulocyte-colony-stimulating-factor-producing hepatocellular carcinoma. J Gastroenterol. 1999;34:640–4.
doi: 10.1007/s005350050387
Amano H, Itamoto T, Emoto K, et al. Granulocyte colony-stimulating factor-producing combined hepatocellular/cholangiocellular carcinoma with sarcomatous change. J Gastroenterol. 2005;40:1158–9.
doi: 10.1007/s00535-005-1715-8
Araki K, Kishihara F, Takahashi K, et al. Hepatocellular carcinoma producing a granulocyte colony-stimulating factor: report of a resected case with a literature review. Liver Int. 2007;27:716–21.
doi: 10.1111/j.1478-3231.2007.01468.x
Joshita S, Nakazawa K, Koike S, et al. A case of granulocyte-colony stimulating factor-producing hepatocellular carcinoma confirmed by immunohistochemistry. J Korean Med Sci. 2010;25:476–80.
doi: 10.3346/jkms.2010.25.3.476
Kohno M, Shirabe K, Mano Y, et al. Granulocyte colony-stimulating-factor-producing hepatocellular carcinoma with extensive sarcomatous changes: report of a case. Surg Today. 2013;43:439–45.
doi: 10.1007/s00595-012-0202-0
Snyder RA, Liu E, Merchant NB. Granulocyte colony stimulating factor secreting hepatocellular carcinoma. Am Surg. 2012;78:821–2.
doi: 10.1177/000313481207800727
Ito T, Okubo K, Shiomi M, et al. A case of successful treatment of granulocyte colony-stimulating factor producing hepatocellular carcinoma accompanying type B hepatitis with tegafur-uracil. Nihon Shokakibyo Gakkai Zasshi. 2012;109:2088–96.
pubmed: 23221058
Nagata H, Komatsu S, Takaki W, et al. Granulocyte colony-stimulating factor-producing hepatocellular carcinoma with abrupt changes. World J Clin Oncol. 2016;7:380–6.
doi: 10.5306/wjco.v7.i5.380
Sakamoto Y, Kamiyama T, Yokoo H, et al. Hepatocellular carcinoma producing granulocyte colony-stimulating factor: diagnosis and treatment. Int Cancer Conf J. 2019;8:12–6.
doi: 10.1007/s13691-018-0346-x
Wang SY, Chen LY, Tsai TF, et al. Constitutive production of colony-stimulating factors by human hepatoma cell lines: possible correlation with cell differentiation. Exp Hematol. 1996;24:437–44.
pubmed: 8599973
Kojiro M, Sugihara S, Kakizoe S, et al. Hepatocellular carcinoma with sarcomatous change: a special reference to the relationship with anticancer therapy. Cancer Chemother Pharmacol. 1989;23:S4-8.
doi: 10.1007/BF00647229
Baba M, Hasegawa H, Nakayabu M, et al. Establishment and characteristics of a gastric cancer cell line (HuGC-OOHIRA) producing high levels of G-CSF, GM-CSF, and IL-6: the presence of autocrine growth control by G-CSF. Am J Hematol. 1995;49:207–15.
doi: 10.1002/ajh.2830490306
Jana S, Patel H. Expression of human granulocyte colony stimulating factor (hG-CSF) in colon adenocarcinoma cell line (Caco-2). Biotechnol Lett. 2012;34:1791–6.
doi: 10.1007/s10529-012-0977-5
Suzuki A, Takahashi T, Okuno Y, et al. Liver damage in patients with colony-stimulating factor-producing tumors. Am J Med. 1993;94:125–32.
doi: 10.1016/0002-9343(93)90173-M
Narsale AA, Carson JA. Role of interleukin-6 in cachexia: therapeutic implications. Curr Opin Support Palliat Care. 2014;8:321–7.
doi: 10.1097/SPC.0000000000000091

Auteurs

Takako Nomura (T)

Department of Gastroenterology and Neurology, Faculty of Medicine, Kagawa University, 1750-1 Ikenobe, Miki-cho, Kita-gun, Kagawa, 761-0793, Japan. takako-n@med.kagawa-u.ac.jp.

Asahiro Morishita (A)

Department of Gastroenterology and Neurology, Faculty of Medicine, Kagawa University, 1750-1 Ikenobe, Miki-cho, Kita-gun, Kagawa, 761-0793, Japan.

Joji Tani (J)

Department of Gastroenterology and Neurology, Faculty of Medicine, Kagawa University, 1750-1 Ikenobe, Miki-cho, Kita-gun, Kagawa, 761-0793, Japan.

Kei Takuma (K)

Department of Gastroenterology and Neurology, Faculty of Medicine, Kagawa University, 1750-1 Ikenobe, Miki-cho, Kita-gun, Kagawa, 761-0793, Japan.

Mai Nakahara (M)

Department of Gastroenterology and Neurology, Faculty of Medicine, Kagawa University, 1750-1 Ikenobe, Miki-cho, Kita-gun, Kagawa, 761-0793, Japan.

Kyoko Oura (K)

Department of Gastroenterology and Neurology, Faculty of Medicine, Kagawa University, 1750-1 Ikenobe, Miki-cho, Kita-gun, Kagawa, 761-0793, Japan.

Tomoko Tadokoro (T)

Department of Gastroenterology and Neurology, Faculty of Medicine, Kagawa University, 1750-1 Ikenobe, Miki-cho, Kita-gun, Kagawa, 761-0793, Japan.

Kiyoyuki Kobayashi (K)

Department of Gastroenterology and Neurology, Faculty of Medicine, Kagawa University, 1750-1 Ikenobe, Miki-cho, Kita-gun, Kagawa, 761-0793, Japan.

Koji Fujita (K)

Department of Gastroenterology and Neurology, Faculty of Medicine, Kagawa University, 1750-1 Ikenobe, Miki-cho, Kita-gun, Kagawa, 761-0793, Japan.

Shima Mimura (S)

Department of Gastroenterology and Neurology, Faculty of Medicine, Kagawa University, 1750-1 Ikenobe, Miki-cho, Kita-gun, Kagawa, 761-0793, Japan.

Hideki Kobara (H)

Department of Gastroenterology and Neurology, Faculty of Medicine, Kagawa University, 1750-1 Ikenobe, Miki-cho, Kita-gun, Kagawa, 761-0793, Japan.

Kunihiko Tsutsui (K)

Department of Gastroenterology and Neurology, Faculty of Medicine, Kagawa University, 1750-1 Ikenobe, Miki-cho, Kita-gun, Kagawa, 761-0793, Japan.

Takayuki Sanomura (T)

Department of Radiology, Faculty of Medicine, Kagawa University, 1750-1 Ikenobe, Miki-cho, Kita-gun, Kagawa, 761-0793, Japan.

Yoshihiro Nishiyama (Y)

Department of Radiology, Faculty of Medicine, Kagawa University, 1750-1 Ikenobe, Miki-cho, Kita-gun, Kagawa, 761-0793, Japan.

Emi Ibuki (E)

Department of Diagnostic Pathology, Kagawa University Hospital, 1750-1 Ikenobe, Miki-cho, Kita-gun, Kagawa, 761-0793, Japan.

Reiji Haba (R)

Department of Diagnostic Pathology, Kagawa University Hospital, 1750-1 Ikenobe, Miki-cho, Kita-gun, Kagawa, 761-0793, Japan.

Teppei Sakamoto (T)

Department of Internal Medicine, Yashima General Hospital, 2105-17, Yashimanishi-machi, Takamatsu, Kagawa, 761-0113, Japan.

Hirohito Yoneyama (H)

Department of Gastroenterology, Saint Martin's Hospital, Tani-machi, Sakaide, Kagawa, 762-0033, Japan.

Takashi Himoto (T)

Department of Clinical Examination, Faculty of Health Sciences, Kagawa Prefectural University of Health Sciences, 281-1 Hara, Mure-cho, Takamatsu, Kagawa, 761-0123, Japan.

Tsutomu Masaki (T)

Department of Gastroenterology and Neurology, Faculty of Medicine, Kagawa University, 1750-1 Ikenobe, Miki-cho, Kita-gun, Kagawa, 761-0793, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH